Table 1.
Baseline characteristics of the study population
| Baseline characteristics | No of patients (n=89) |
| Age (years) | 66.2±9.8 |
| Males (%) | 78 (88) |
| Median follow-up time (months) | 66.3 (52.3; 77) |
| Presentation (%) | |
| Chronic coronary syndrome | 58 (65) |
| Acute coronary syndrome | 31 (35) |
| STEMI | |
| NSTEMI | |
| Cardiovascular risk factors (%) | |
| Arterial hypertension (%) | 67 (75) |
| Diabetes mellitus (%) | 24 (27) |
| Dyslipidaemia (%) | 70 (79) |
| Current smoking (%) | 49 (55) |
| Previous MI (%) | 42 (47) |
| Previous CABG (%) | 9 (10) |
| Antithrombotics (%) | |
| Aspirin | 88 (99) |
| Clopidogrel | 59 (66) |
| Ticagrelor | 14 (16) |
| Prasugrel | 16 (18) |
| Oral anticoagulant | 3 (3.4) |
| Access (%) | |
| Radial | 74 (83) |
| Femoral | 15 (17) |
Data are mean (SD), median (IQR) or number (percentage), as appropriate.
CABG, coronary artery bypass grafting; MI, myocardial infarction; NSTEMI, non-ST segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction.